Skip To Main Content
Yuanquan Yu on Muck Rack

Yuanquan Yu

As seen in: Frontiers, Cell Reports Medicine
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Yuanquan

Contact Yuanquan, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Phylogenomics-driven metalloantibiotic engineering: Overcoming ciprofloxacin resistance in Pseudomonas aeruginosa with sideromycin-bismuth synergy

|
By Jianwei Chen, Jiangwei Pan, Xingyue Lu, Lu Wang, Yujie Yue, Liting Gu, Siqi Wang, Minghong Chen, Hong Jiang, Yu Pan, Yuanquan Yu, Jianwei Nai, Dahong Zhang, Hong Wang, Keli Tan
| Cell Reports Medicine Verified
Keywords metalloantibiotic P. aeruginosa siderophore sideromycin Introduction Antibiotic-resistant bacterial infections pose a growing threat to global health.
Open in Who Shared Issue with article?

Determinants and survival benefits of achieving textbook outcome for intrahepatic cholangiocarcinoma in the era of neoadjuvant therapy

|
By Jiawei Hu, Yihang Wang, Haoran Diao, Xiaoxiao Zhang, Qi Li, Yun Jin, Jiangtao Li, Shuangda Miao, Yanzhi Pan, Yuanquan Yu
| Frontiers
Introduction Intrahepatic cholangiocarcinoma (ICC) is a malignant tumor that originates from the intrahepatic biliary epithelium, accounting for approximately 10%–20% of all cholangiocarcinoma cases. It is the second most common primary liver malignancy, constituting approximately 10% of all primary liver cancers (1, 2). The global incidence of ICC has been significantly increasing in recent years (3).
Open in Who Shared Issue with article?
See all 2 articles